Sustainability | September 12, 2023
JB Pharma publishes sustainability report for FY 2022-23
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
Cipla has a robust governance model focused on sustainability
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
Profit After Tax (PAT) for the quarter ended December 31, 2022 was at Rs. 290.8 crore as compared to Rs. 239.8 crore in the previous corresponding quarter, registering a growth of 21.3% YoY
The forecast across the seven years between 2022 and 2028 saw an average decline of 7%, resulting in a $10 billion drop in the total forecast sales between 2021 and 2028
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
Biocon Foundation has pioneered a mHealth-technology-based (mobile health) oral cancer screening program in India
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
Patients receiving Polivy plus R-CHP for DLBCL reported similar health-related quality of life outcomes
The 9th World Ayurveda Congress and Arogya Expo 2022 aims to showcase the efficacy and strength of the AYUSH systems of medicine at the global level
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)